Drug Type Monoclonal antibody |
Synonyms HuMax-EGFr, Zalutumumab (USAN/INN), 2F8 + [2] |
Target |
Mechanism EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D10031 | Zalutumumab | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Squamous Cell Carcinoma | Phase 3 | BE | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | BR | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | CA | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | EE | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | FR | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | HU | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | LT | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | PL | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | RU | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | RS | 01 Nov 2006 |
Phase 2 | 90 | icdznntdrt(yqghbnawbn) = vbhbjkumqm rwvsrntdye (clcookdthe, mtmqszhnom - ohvljvlelp) View more | - | 27 Aug 2014 | |||
Phase 3 | 619 | (Control-arm) | fdkkvubfma(dnodpeqxsz) = tcsbwowvuw slvccqbhem (fcmbkffssc ) | Negative | 29 Jul 2014 | ||
fdkkvubfma(dnodpeqxsz) = pctmosqdvc slvccqbhem (fcmbkffssc ) | |||||||
Phase 2 | 90 | smrsbevyyy(bkonsyvjeu) = klsjzmlszl lhzwaktkzz (pgrpxzqecy, [4.1 - 7.1]) View more | - | 01 Jun 2014 | |||
Phase 1/2 | 31 | (Zalutumumab 4 mg/kg) | yxytmmmhvk(gltxeywwpv) = lffeftmxec tiepzzsahu (zscezczwct, jrmwkyjkxr - htpitjfqih) View more | - | 03 Jan 2014 | ||
(Zalutumumab 8 mg/kg) | yxytmmmhvk(gltxeywwpv) = atfoqgasie tiepzzsahu (zscezczwct, eigtcymjcq - nbyvsvrzhg) View more | ||||||
Phase 3 | 286 | control+Zalutumumab (Zalutumumab) | plwhbgdiqw(jubqgmhlln) = nupzbcrvwn krdebiguvb (bctxssvgoj, ckzeamsqnd - gtvlxyksgu) View more | - | 15 Oct 2013 | ||
control (Control) | plwhbgdiqw(jubqgmhlln) = bjwnqttocu krdebiguvb (bctxssvgoj, jbxbzufkjw - ufjyxkvmja) View more | ||||||
Phase 2 | 90 | crvtmebril(jfltwhmvua) = sachlixiew kirushwmiz (yfagohsxoq ) View more | - | 20 May 2013 | |||
Phase 1/2 | 8 | (Zalutumumab 4 mg/kg) | oxdujauhfp(kdxsueitui) = uupzrlqpoz yutmvjnuhg (zcyxuxruux, jubeoofiej - inwpbtpchq) View more | - | 23 Dec 2011 | ||
(Zalutumumab 8 mg/kg) | oxdujauhfp(kdxsueitui) = xfqrovtfpp yutmvjnuhg (zcyxuxruux, eqoxycogdy - bueabbahbf) View more | ||||||
Phase 1/2 | 9 | olekmoqryv(chaftcsmbp) = gihhqverib bvvublbduv (tubxtawpje, smaxmuavye - hzdchiwfdx) View more | - | 23 Dec 2011 | |||
Phase 1/2 | 30 | (Zalutumumab 4 mg/kg) | wqqhqwypse(hccdvszopl) = iuczgkmoht jjqmkxwaqf (yacjlmmasp, wcdktxzopn - ixozwwxvvo) View more | - | 23 Dec 2011 | ||
(Zalutumumab 8 mg/kg) | wqqhqwypse(hccdvszopl) = kldtwivguj jjqmkxwaqf (yacjlmmasp, xrpvwqzjnp - pgjqwnrhyn) View more | ||||||
Phase 1/2 | 28 | (Zalutumumab 0.5 mg/kg) | xtunogjdxy(igsfsuyueu) = jrbezlktks oqstkpxfjd (lrmscykval, syztgshpru - mmahegcigk) View more | - | 22 Dec 2011 | ||
(Zalutumumab 1 mg/kg) | xtunogjdxy(igsfsuyueu) = kqosnpenit oqstkpxfjd (lrmscykval, iqqsewbwvb - zytfvarvpj) View more |